Zde se nacházíte:
Informace o publikaci
Safety and Efficacy of Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells in Patients with Epidermolysis Bullosa: Clinical Trial Phase I/II 12/10/2023 – 11/10/2024
| Autoři | |
|---|---|
| Rok publikování | 2024 |
| Druh | Výzkumná zpráva |
| Fakulta / Pracoviště MU | |
| www | MSC-EB |
| Popis | The second periodic safety report for the „Safety and Efficacy of Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells in Patients with Epidermolysis Bullosa: Clinical Trial Phase I/II“ (acronym MSC-EB) evaluates the safety data received by the sponsor (Masaryk University Brno) during the period 12/10/2023 to 11/10/2024. The CT is performed in 2 centers in the Czech Republic |